Recombinant Proteins companies

Key Recombinant Proteins Market Players:

Here is a list of key players operating in the global market:

• Thermo Fisher Scientific (U.S.)
• Bio-Techne (U.S.)
• GenScript (China)
• Abcam (UK)
• Elabscience (China)
• Shanghai Bao Pharma Co., Ltd. (China)
• Biomay AG (Austria)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis

The global market is extremely competitive, and it hosts leading manufacturers who are benefiting from broad portfolios, in-house expression and purification capabilities, and extensive geographic reach. Competition in this sector is largely driven by product breadth across cytokines, growth factors, enzymes, target proteins, and GMP-grade offerings, along with bioactivity, purity, low endotoxin levels, scalability, and lot-to-lot consistency. In May 2026, Sanofi stated that Phase 2 ElevAATe data presented at the 2026 ATS International Conference showed that investigational efdoralprin alfa was superior to weekly plasma-derived augmentation therapy in raising and maintaining functional alpha-1 antitrypsin (fAAT) levels in patients with AATD-related emphysema. These results support efdoralprin alfa’s potential as a recombinant protein therapy.

Corporate Landscape of the Market:

• Thermo Fisher Scientific holds a strong position in this sector, which is propelled through its Gibco recombinant protein portfolio, i.e., NAP-2 recombinant human protein. The company competes through an extensive product range, strong quality standards, and worldwide reach.
• Bio-Techne, through R&D Systems, supplies recombinant proteins including cytokines, growth factors, and enzymes. The firm differentiates itself through product breadth, high purity, bioactivity validation, and application-specific offerings.
• GenScript provides a broad recombinant protein portfolio, i.e., recombinant human PD-L1 proteins produced using mammalian expression systems. In addition, the firm’s key strengths include diverse expression technologies, protein engineering capabilities, and products supporting drug discovery as well as biopharmaceutical research.
• Abcam provides a huge range of recombinant proteins for research applications, including recombinant human Hsc70 protein. Also, the company deliberately competes through product quality, detailed characterization, and a strong global life sciences presence.
• Elabscience manufactures a diverse range of recombinant proteins, including recombinant human LBP protein. The firm is highly focused on broad product availability, competitive pricing, defined quality specifications, and a wide range of applications spanning immunology, molecular biology, and biomedical research.